TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol.14, no.4, pp.199-202, 2017 (ESCI)
Objective: The aim of this study was to compare the effect of corifollitropin alfa (CFA) and recombinant follicle-stimulating hormone (rFSH) in poor-responder patients undergoing antagonist cycles.